Snappy newsletters. Simple Facebook sharing. Spirited comments. Sweet features are waiting… GET THEM NOW!

Hot on Facebook

'Serpent Pastor' Dies of Snake Bite Mack Wolford believed faith compelled him to face the risk »

FDA Ignored Data on Risky MRI Dye

Failed to single out role of GE dye, Omniscan, in onset of disease

By Kevin Spak, Newser Staff

Posted Oct 16, 2009 8:51 AM CDT

(Newser) – In May 2006, Danish medical regulators came to GE with troubling findings. Twenty-five patients with weak kidneys had developed NSF, a rare and sometimes fatal disease, after undergoing MRIs, and all 25 had been injected with GE’s Omniscan dye. Since then, the GE dye,... Read full story »

COMMENTS

Read the comment policy

You need to Log in to Newser to comment. Don't have an account yet? Sign up now!

5 comments

A snapshot of the day's best news stories.

View Larger Grid

All Today Yesterday Pick a Date

What's Popular Now on Facebook

'Serpent Pastor' Dies of Snake Bite

Miami Face-Eater Identified

ProPublica (Source Grid »)

Money • Health

FDA • General Electric • MRI • Food and Drug Administration • medical technology • Omniscan

More Newser Stories

Feds Back Weight-Loss Pill Qnexa

Step toward first FDA-approved diet drug in years

(NEWSER) - A federal panel's decision has brought us a step closer to the first FDA-approved prescription weight-loss drug in more than 10 years. Qnexa was earlier rejected by the FDA over possible safety risks, but the non-FDA panel found, by a vote of 20-2, that the drug's benefits outweigh such risks, the Wall Street Journal reports. The decision effectively urges FDA approval for sale; the agency will decide by April 17. More»

FDA to Probe Inhalable Caffeine

Senator Shcarles Schumer questions whether it's safe for kids

(NEWSER) - New York Sen. Charles Schumer isn't convinced inhalable caffeine is a good thing—at least not for kids, the AP reports. He has helped prod the FDA into investigating chapstick-sized caffeine inhalers called Aeroshots. The senator says his concern was prompted by incidents last year when students guzzled too many caffeinated alcoholic drinks for a quick buzz. Kids and teens "are particularly vulnerable to overusing a product," says Schumer. More»

FDA Whistleblowers: Our Email Was Monitored

Group of employees files lawsuit

(NEWSER) - A group of FDA scientists and doctors says that their personal emails were monitored by the agency after they acted as whistleblowers, and that the information gleaned from the surveillance led to their harassment or dismissal. The employees had complained internally, beginning in 2007, about approved or soon-to-be-approved cancer-screening devices that they believed posed risks to patients. Ultimately, they told Congress, the White House, and the Health and Human Services inspector general about their concerns, the Washington Post reports. More»

Feds Hit Red Cross With $9.6M Fine

FDA sites badly trained staff, poor record-keeping

(NEWSER) - The feds have slapped the American Red Cross with a $9.6 million fine for careless blood management practices, MSNBC reports. The FDA uncovered no actual harm to blood recipients, but expressed concern over poorly trained staff and slipshod record-keeping: We "cannot definitively say there was never any danger to the blood supply since the violations can create conditions that could lead to potential safety consequences,” an official said. More»

E-Cigs Work, But Have Smoking Foes Burning

They can help smokers quit, but anti-smoking groups still want ban

(NEWSER) - A recent experiment in Italy found that electronic cigarettes can help even hard-core smokers quit, boosting hopes that e-cigarettes could be a much better tool than more traditional products like nicotine patches and gum. So why are government officials and anti-smoking groups working to ban the device, which delivers a small amount of nicotine in an aerosol form? The New York Times takes an extensive look at the issue, and points out an odd reality: It’s the more liberal officials who are touting an "abstinence-only" policy when it comes to smoking cessation tools. More»

NEWS FROM OUR PARTNERS

What is Newser?

Face it: there's too much news. At Newser, we choose the most thought-provoking and entertaining stories from hundreds of US and international sources and reduce them to a headline, picture, and two paragraphs. And we do it 24/7—you can come back morning, noon, night (and in between) for something new that matters. Read less, know more.

Learn more »

Partnering with: Slate

View Newser on the mobile website

FDA Ignored Data on Risky MRI Dye

Failed to single out role of GE dye, Omniscan, in onset of disease

FDA • General Electric • MRI • Food and Drug Administration • medical technology • Omniscan

MOST POPULAR STORIES

[ By Views ]

[ By Comments ]

More Newser Stories

Feds Back Weight-Loss Pill Qnexa

Step toward first FDA-approved diet drug in years

FDA to Probe Inhalable Caffeine

Senator Shcarles Schumer questions whether it's safe for kids

FDA Whistleblowers: Our Email Was Monitored

Group of employees files lawsuit

Feds Hit Red Cross With $9.6M Fine

FDA sites badly trained staff, poor record-keeping

E-Cigs Work, But Have Smoking Foes Burning

They can help smokers quit, but anti-smoking groups still want ban

About Us

Site

Community

Site Maps

Tools

More News

What is Newser?